Web of Science: 2 cites, Scopus: 3 cites, Google Scholar: cites
Can a mobile application improve glucose-related and patient-reported outcome measures (PROMs) in people with type 1 diabetes mellitus? A randomized controlled trial using the mySugr® app
Cuixart, Gemma (Institut de Recerca Sant Pau)
Corcoy i Pla, Rosa (Universitat Autònoma de Barcelona. Departament de Medicina)
González, Cintia (Hospital de la Santa Creu i Sant Pau (Barcelona, Catalunya))

Data: 2024
Resum: Purpose: Mobile applications (apps) have proven to be highly effective tools to empower patients with type 1 diabetes mellitus (T1DM) and enable them to achieve better self-care, quality of life (QOL), and glycemic control. The aim of the study is to examine whether mySugr, an app for diabetes management, together with teleconsultations, can have a positive impact on these factors and, thereby, replace current clinical care. Methods: This study concerns an exploratory randomized clinical trial of 12 months' duration. People with T1DM using multiple daily injections were randomized to usual care (bolus calculator, five face-to-face visits) or intervention (mySugr app, three face-to-face visits, and two teleconsultations). The main outcome was increase in empowerment assessed with the Diabetes Empowerment Scale Short Form questionnaire (DES-SF-S). Secondary outcomes were change in additional glucose-related (blood glucose monitoring, mean blood glucose, standard deviation, coefficient of variation (CV), and high and low blood glucose index) and patient-reported outcome measures (PROMs) (self-management, QOL, and distress). Results: A total of 25 out of 28 participants completed the study (52% men, age 44. 52 years, diabetes duration 21. 28 years). At 12 months, no significant differences were identified in the change of DES-SF-S and additional PROMs between arms. Similarly, no differences were observed in glucose-related outcomes except for the change in CV at 9 (control - 1. 87 ± 4. 98 vs. intervention 5. 89 ± 11. 33, p = 0. 008) and 12 months (control - 2. 33 ± 3. 54 vs. intervention 5. 12 ± 11. 32, p = 0. 018). Adherence to and satisfaction with the app were high. Conclusion: Patients with diabetes using the mySugr app and teleconsultation achieved similar results to those following usual care in empowerment, other PROMs, and most glucose-related outcomes, thus supporting its use in combination with face-to-face visits. The RCT was registered with ClinicalTrials. gov (NCT03819335, first registration 28/01/2019).
Nota: Altres ajuts: acords transformatius de la UAB
Drets: Aquest document està subjecte a una llicència d'ús Creative Commons. Es permet la reproducció total o parcial, la distribució, la comunicació pública de l'obra i la creació d'obres derivades, fins i tot amb finalitats comercials, sempre i quan es reconegui l'autoria de l'obra original. Creative Commons
Llengua: Anglès
Document: Article ; recerca ; Versió publicada
Matèria: Ehealth ; Empowerment ; Mhealth ; Mobile application ; Telemedicine ; Type 1 diabetes mellitus
Publicat a: Hormones (Cham.), 2024 , ISSN 2520-8721

DOI: 10.1007/s42000-024-00609-z
PMID: 39412732


11 p, 1.2 MB

El registre apareix a les col·leccions:
Documents de recerca > Documents dels grups de recerca de la UAB > Centres i grups de recerca (producció científica) > Ciències de la salut i biociències > Institut de Recerca Sant Pau
Articles > Articles de recerca
Articles > Articles publicats

 Registre creat el 2024-11-12, darrera modificació el 2025-10-12



   Favorit i Compartir